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Pediatric Congenital Heart Diseases in TaiwanCongenital heart disease (CHD) is the most prevalent group
of congenital anomalies and the most frequent cause of
death in young populations. Over the past century,
advances in cardiovascular diagnostics, medicine, inter-
ventional catheterization, cardiac surgery, and intensive
care led to an increased survival of newborns with CHD.
Consequently, more patients with CHD reach adulthood,
creating a completely new and steadily growing patient
population: patients with adult congenital heart disease.
These patients often need numerous hospitalizations, the
use of multidisciplinary teams of specialists for necessary
treatment, and the use of social services. Therefore, CHD is
associated with a considerable disease burden at both
national and individual levels. By contrast, accurate
reporting of the prevalence of CHD plays an important role
in health care planning as well as etiological investigations.
Furthermore, researchers can find geographical or temporal
differences via comparing with other studies.
In Taiwan, the first clinical study of CHD, with more than
200 patients enrolled, was a hospital-based study con-
ducted in 1962 based on cases collected over a 5-year
period at National Taiwan University Hospital.1 It showed
that the five most common subtypes were ventricular
septal defect (VSD), tetralogy of Fallot (ToF), patent ductus
arteriosus (PDA), pulmonary valve stenosis (PS), atrial
septal defect, type II (ASDII) in the late 1960s. Female
predominance was observed in PDA; and male predomi-
nance was observed in ToF. With the help of a nationwide
National Health Insurance program implemented in Taiwan
from 1995, hospital-based studies turned into population-
based studies with direct collection on registry-based
data and later population-based epidemiologic studies on
pediatric CHD. These studies reported the CHD prevalence
at live birth in Taiwan was 13.08/1000, with 12.05 (simple,
10.53; severe, 1.51) in male infants and 14.21 (simple,
12.90; severe, 1.32) in female infants.2 The five most
common CHD subtypes were VSD, ASDII, PDA, PS, and ToF,
with a change in the order of prevalence for different
subtypes as compared to the 1962 reports. Postnatal
echocardiographic diagnosis for minimal cardiac symptoms,1875-9572/$36 Copyright ª 2013, Taiwan Pediatric Association. Publish
http://dx.doi.org/10.1016/j.pedneo.2012.12.020such as heart murmur alone or even as a means of new-
born screening, may increase the detection rate of less
severe types of CHD, such as VSD, PDA, and ASDII. Dif-
ferences in prevalence by sex disclosed in this study were
in general agreement with the earlier reports, including
female predominance in VSD, ASDII, PDA, and endocardial
cushion defect, and male predominance in transposition
of great aorta and ToF. In this issue of the Pediatrics and
Neonatology, Yeh et al3 further elucidate the prevalence
and mortality of pediatric CHD in Taiwan. The five most
frequently diagnosed CHDs and their prevalence were
consistent with a former study.2 Age-specific prevalence
of both simple and severe CHDs declined rapidly after
age 10 years. Over 90% of CHD-related deaths occurred by
age 5 years. Some CHDs with low prevalence, such as
coarctation of aorta and aortic valve stenosis, are ana-
lyzed and further discussed in this population-based
study.
With increasing global wealth and a better under-
standing on the CHD-related burden of diseases by the
population and health officials’ knowledge, many
population-based studies were conducted in western
countries.4,5 These works provided informative data for
further systematic review and meta-analysis on pediatric
CHD.6,7 These studies revealed significant geographical
differences among countries with Asia reporting the
highest CHD birth prevalence, more pulmonary outflow
obstructions (PS and TOF), and fewer left ventricular
outflow tract obstructions (coarctation of aorta and aortic
valve stenosis) and transposition of great aorta. These
observed differencesmay be associated with different
genetic, environmental, socio-economic, or ethnicity
factors, and need to be further investigated. Advanced
technology in diagnostic methods and screening modal-
ities may also increase the reported CHD birth prevalence
rather than representing a true increase in disease prev-
alence, with the proportion of VSD, ASDII, and PDA having
increased significantly in the past four decades. However,
a considerable discrepancy with extraordinarily high CHD
incidence in Taiwan (32.5/1000) was reported in someed by Elsevier Taiwan LLC. All rights reserved.
68 Editorialstudies.5,6 Therefore, using recent population-based
studies, we have more confidence in correctly estimat-
ing the prevalence or incidence of CHD in Taiwan.2,3
Taking advantage of the powerful National Health Insur-
ance registry database, which covers more than 98% of
the Taiwan population since 1995, we can conduct
population-based studies without institutional bias6 and
acquire results on CHD prevalence, mortality, and disease
burden in Taiwan for future international comparison.3
These datasets underscore the need for periodic updat-
ing and will be an important reference for relevant
healthcare policy-making to provide more specialized
care to young patients with CHD in Taiwan.
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